People

PhD, Molecular Biology & Biomedical Science, Meharry Medical College
BS, Biology Texas A & M University

Evidence-based interventions, Non-communicable diseases

Emmanuel Peprah is the director of Implementation Science for Global Health and Implementing Sustainable Evidence-based interventions through Engagement (ISEE Lab) at the New York University School of Global Public Health. He has extensive experience developing a portfolio of funded research that addresses the burden of both infectious and non-communicable diseases by utilizing methods that promote the uptake of evidence-based interventions (EBIs) into routine clinical practice and community settings. His research interests lie at the confluence of understanding what, why, and how some EBIs work in some populations and not others in low- and middle-income countries. The programmatic focus of his research is understanding the contextual factors that influence the burden of co-morbidity in people living with HIV/AIDS (PWH) with a particular focus on non-communicable diseases including substance abuse. As the burden of non-communicable diseases (NCDs) continue to increase, there is an opportunity to integrate NCD management into HIV care with implementation strategies that leverage the global infrastructure designed to improve care delivery for PWH.

Before joining NYU GPH, Dr. Peprah was a senior program official at the National Institutes of Health (NIH), where he worked with senior leadership to oversee strategic planning, initiative development, and implementation of research priorities in the areas of translational research, implementation science, and global health. He led and managed HIV/AIDS programs and a $10 million portfolio as part of the National Heart, Lung, and Blood Institute’s Trans-Omics for Precision Medicine Program. During his tenure at the NIH, Dr. Peprah developed several funding opportunity announcements focused on utilizing implementation research to address the high burden of NCDs in low resource settings including two initiatives (~$50 Million) utilizing implementation research to address co-morbid conditions in PWH. He was instrumental in launching the Human, Heredity, and Health in Africa (H3Africa) Initiative, a multimillion trans-NIH program. Dr. Peprah has received several awards for strategic planning, management, and implementation of large-scale NIH programs.

Recent

Dr. Peprah's Publications in PubMed